POPULARITY
16 episodes with shubham
4 episodes with shubham
3 episodes with shubham
5 episodes with shubham
13 episodes with shubham
2 episodes with shubham
2 episodes with shubham
2 episodes with shubham
4 episodes with shubham
Drawing from over two decades of musical training and deep roots in Ayurvedic philosophy, Dr. Shubham explains how ancient healing modalities like sound, music, and raga-based therapy can support emotional, psychological, and spiritual well-being to manage depression, insomnia, and anger.The conversation then turns to one of the most intimate and often overlooked areas of medicine: end-of-life care. Dr. Shubham shares his experiences working with terminally ill patients and reflects on the five stages of grief through deeply personal stories.This episode is a gentle, powerful reminder that understanding death helps us better understand life, and that caregivers, families, and physicians play a sacred role in helping others let go with dignity, grace, and peace.Topics Covered:Indian classical music for therapySpecific ragas for mental health supportEnd of life careThe five stages of grief Peaceful Death Timestamp:00:00 - 09:30: Integration of Ayurveda & Musical Therapy 09:30 - 19:30: Ragas for Anxiety, Sleeplessness, and more19:30 - 25:30: End of life care for the terminally ill 25:30 - 30:00: Living or Leaving? What do most choose?30:00 - 35:00: The five stages of grief35:00 - 42:00: Greatest Wish: Peaceful Death42:00 - 1:00:00: Accepting Death & Dependence1:00:00 - 1:12:06: Music Therapy About Dr. Shubham KulkarniDr. Shubham Kulkarni is a compassionate healer and multi-faceted expert in Ayurveda, music therapy, mental health, palliative care, end-of-life care, spirituality, and Indian classical music. With a profound understanding of holistic well-being, Dr.Kulkarni combines ancient wisdom with modern practices to guide individuals on their journey to health and harmony.If you are interested in doing one to one Ayurvedic consultation with Dr Vignesh Devraj, please find the details in this link: https://calendly.com/drvignesh/30-minute-session-with-dr-vignesh-devraj-md-ay-istIf you are economically challenged, please use the form provided to request a free Ayurvedic consultation here. (or copy paste this in your browser: https://docs.google.com/forms/d/e/1FAIpQLSd29nHcrC1RssR-6WAqWCWQWKKJo7nGcEm8ITEl2-ErcnfVEg/viewform )BALANCE THE MIGHTY VATA - ONLINE COURSE NOW AVAILABLE What makes Ayurveda unique in its treatment approach is its practical wisdom on the concept of Vata. Vata is responsible for Prana - the life energy, nervous system - the master panel of our body, and our emotions. In Ayurveda, it is mentioned that controlling Vata is the most difficult part of healing and recovery. Recently, I have recorded a workshop on - Balancing The Mighty Vata which has over 6 hrs of content, with notes filled with practical inputs that can be integrated into our life. You can access this at https://drvignesh.teachable.com/For further information about Dr Vignesh Devraj, kindly visit www.vigneshdevraj.com and www.sitaramretreat.com Instagram - @sitarambeachretreat | @vigneshdevrajTwitter - @VigneshDevrajWe truly hope you are enjoying our content. Want to help us shape and grow this show faster? Leave your review and subscribe to the podcast, so you'll never miss out on any new episodes. Thanks for your support.Disclaimer: - The content of the podcast episodes is not intended to be a substitute for professional medical procedures, consultations, diagnosis, or treatment in any manner. We strongly do not recommend using the content of these episodes as medical advice for any medical conditions for you, others, or for treating your patients.
In today's episode, we spoke with Shubham Pant, MD, MBBS, and Professor Timothy Elliott, about ongoing research with cancer vaccines. Dr Pant is a professor in the Department of Gastrointestinal Medical Oncology in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston. Dr Elliott is the Kidani Professor of Immuno-oncology in the Nuffield Department of Medicine at the University of Oxford in the United Kingdom. In our exclusive interview, Pant and Elliott discussed the current landscape of vaccines for cancer treatment, ongoing research seeking to extend the benefits of vaccines as cancer management and prevention strategies, and what the future may hold.
Shubham Gupta: The Analytical SpeakerShubham Gupta is an analytics and business intelligence leader who, as part of his work, communicates analytics and AI insights to non-technical audiences. He's worked in a number of industries, including telecom, healthcare, and insurance. I'm curious to learn more about why he chose his field of expertise, and why speaking to non-technical audiences became of importance to him. To get in touch with Shubham, visit https://www.linkedin.com/in/shubham-gupta-hbs.__TEACH THE GEEK (http://teachthegeek.com) Prefer video? Visit http://youtube.teachthegeek.com.Follow @teachthegeek (Twitter) and @_teachthegeek_ (IG) Get Public Speaking Tips for STEM Professionals at http://teachthegeek.com/tips
Inspired by the old and the new, this radio show takes you through the journey of our beloved electronic music genre, drum and bass. Right from The Amen sample all the way to the new age bass stalwarts, this series promises to take you on a journey through wobbling basslines and futuristic loops. Enjoy and keep raving. ---------- Follow Shubham_ (@shubsham) ◊ www.instagram.com/shubsham_ ◊ www.mixcloud.com/djshsh/ ---------- Follow MSYH.FM » MSYH.FM » x.com/MSYHFM » instagram.com/MSYH.FM » facebook.com/MSYH.FM » patreon.com/MSYHFM ---------- Follow Make Sure You Have Fun™ ∞ MakeSureYouHaveFun.com ∞ x.com/MakeSureYouHave ∞ instagram.com/MakeSureYouHaveFun ∞ facebook.com/MakeSureYouHaveFun ∞ youtube.com/@MakeSureYouHaveFun ∞ twitch.tv/@MakeSureYouHaveFun
I'm excited to share our latest episode of the Tech On Toast podcast, where we dive deep into the world of technology in the fine dining industry. This week, we had the pleasure of visiting Benares in Mayfair, a Michelin-starred Indian restaurant, and speaking with Shubham and Mark from TISL. Together, we explored the challenges and triumphs of implementing technology in a bustling restaurant environment.Here are three key takeaways from our conversation that I believe are crucial for anyone in the tech or hospitality sectors:The Importance of Support: One of the standout themes from our discussion was the critical role that support plays in the success of technology implementation. Shubham emphasised how TISSL's support team is always just a phone call away, ready to resolve issues in real-time, even during the busiest hours. This level of accessibility not only alleviates stress but also ensures that operations run smoothly, allowing staff to focus on delivering exceptional customer experiences.Simplicity is Key: In a fast-paced environment like a restaurant, simplicity in technology is paramount. Both Shubham and Mark highlighted how TISSL's system is designed to be user-friendly, enabling staff to manage orders and make adjustments quickly, even from their phones. This agility is essential for maintaining efficiency and minimising errors, especially during peak service times. It's a reminder that technology should enhance operations, not complicate them.Building Strong Relationships: The relationship between Benares and TISSL is a testament to the power of collaboration and trust. After a brief period with another provider, Benares returned to TISSL, citing the reliability and support they received as key factors in their decision. This episode reinforces the idea that successful partnerships are built on understanding, communication, and a shared commitment to excellence.I invite you to listen to the full episode to gain deeper insights into how technology can transform the dining experience and the importance of having the right support system in place.Thank you for tuning in, and I look forward to hearing your thoughts on this episode! Let's continue the conversation about how we can leverage technology to create better experiences in our industries.#TechOnToast #Podcast #Hospitality #Technology #Support #Simplicity #Relationships #FineDining
My guests today are Martin Spinnangr and Shubham Bhattacharya, CPO at Munu and former CPO at Favrit - two Nordic rivals in the world of hospitality SaaS. We talked about what it takes to build and scale a vertical SaaS product, the challenges of defining your ideal customer profile, why most product validation efforts fail, acquisition vs. retention, the real cost of poor strategic alignment, and more. Shubham is currently a Lead PM at Xeneta and Martin has been a Product leader in Laerdal Medical and Easee before Munu - so this conversation brings different perspectives to the table and it was good to connect with these two again! Enjoy :) This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit afonsofranco.substack.com
Host: Tracy Shuchart for MicDropMarketsGuests: AbdulazizAbdulaziz is a prominent Public Saudi figure on Energy and Climate issues and a publicspeaker for major energy issues for the chamber of commerce, municipalities andmany other entities in the MiddleEast. For the past 15 years Abdulaziz has been an avid observer in the E&P activitiesin the MENA region. Rob ConnersRob Connors spent +15 years as a sell-side research analyst covering variouscompanies in the oil & gas, industrials, transportation and aerospace &defense sector. He majored in finance from the University of Maryland andobtained the CFA and CPA designations. Rob started what eventuallybecame the Crude Chronicles in 2020 which specializes in telling thefinancial history of the Oil & Gas industry with data going back to theindustry's founding. Patrick De HannPatrick has analyzed and tracked oil markets and fuel prices for nearly two decades.Patrick has concentrated on downstream oil markets, including crude oil,gasoline, diesel and jet fuel since 2005. Patrick started with GasBuddy in 2009the largest U.S. fuel-price tracking service in existence, providing expertisefor millions of users. Since his start, he has provided regular commentary toU.S. News and World Report and is often quoted during gas price gyrations andfuel disruptions by almost all U.S. and international media outlets.Shubham GargShubham Garg is the CEO & Founder of White Tundra Resources and White TundraInvestments. Shubham launched White Tundra Resources in 2019 as a company forcontract field production operations, production optimization and engineeringsupport. He is currently managing White Tundra Investments' portfolio focusedon undervalued Canadian Oil & Gas E&P's. White Tundra operates on aconcentrated model with 15-30% of their portfolio invested in one leveragedhigh-torque equity, 40-60% on a basket of low-growth cash-flow generatingequities, and 15-50% on high potential small-cap and junior companies withunique technology.Disclaimer: This material is presented solely forinformational and entertainment purposes and is not to be construed as a recommendation,solicitation, or an offer to buy or sell / long or short any securities,commodities, or any related financial instruments. Please contact a licensedprofessional before making any investment or trading decisions
Inspired by the old and the new, this radio show takes you through the journey of our beloved electronic music genre, drum and bass. Right from The Amen sample all the way to the new age bass stalwarts, this series promises to take you on a journey through wobbling basslines and futuristic loops. Enjoy and keep raving. ---------- Follow Shubham_ (@shubsham) ◊ https://www.instagram.com/shubsham_ ◊ https://www.mixcloud.com/djshsh/ ---------- Follow MSYH.FM » http://MSYH.FM » http://x.com/MSYHFM » http://instagram.com/MSYH.FM » http://facebook.com/MSYH.FM » http://patreon.com/MSYHFM ---------- Follow Make Sure You Have Fun™ ∞ http://MakeSureYouHaveFun.com ∞ http://x.com/MakeSureYouHave ∞ http://instagram.com/MakeSureYouHaveFun ∞ http://facebook.com/MakeSureYouHaveFun ∞ http://youtube.com/@MakeSureYouHaveFun ∞ http://twitch.tv/@MakeSureYouHaveFun
Le travail au bureau est déjà mort.L'ère du digital a créé toute une économie basée sur le monde numérique. Les métiers derrière un bureau se sont multipliés mais l'IA est en train de tout disrupter.La fin des SaaS ? Des PowerPoints et des “bullshit jobs” ?Shubham Sharma est ingénieur de formation et geek dans l'âme. Ses 200k abonnés sur YouTube le suivent pour découvrir comment le NoCode peut améliorer leur quotidien et les rendre plus libres.Pape de l'automatisation, il partage ses meilleures stratégies pour retrouver le contrôle de nos vies numériques tant pro que perso.Shubham apporte une incroyable valeur ajoutée dans chacune de ses vidéos et formations. Résultat : il change la vie de milliers de personnes en démystifiant la tech et le code.On explore :Le potentiel des agents IA en 2025, et la disparition des SaaSPourquoi apprendre à coder est encore importantLes automatisations qui vous rendront libresGuide d'initiation pour utiliser Notion, Make et ZapierComment atteindre l'Inbox ZéroPourquoi et comment se lancer sur YouTubeUn épisode clef pour retrouver sa liberté en gagnant du temps. Absolument crucial pour ne plus rester spectateur de la révolution IA, mais en devenir acteur.PS : J'ai négocié pour vous le code promo 'DOIT' qui vous permettra de bénéficier de 30% de réduction sur les formations de Shubham.Shubham a créé un petit quiz pour tester vos connaissances à la fin de l'épisode : https://lnkd.in/gmtiAJK2 (partagez-nous votre score en commentaire sur le post Insta).TIMELINE:00:00:00 : Le travail au bureau est déjà mort (et c'est bien)00:14:37 : Pourquoi les grandes entreprises sont si lentes pour adopter l'IA00:22:53 : Comment bien "geeker” jusqu'à faire des projets immobiliers00:34:06 : Utiliser l'IA pour décupler sa productivité00:45:18 : Les automatisations qui changent TOUT00:53:56 : Le potentiel des agents IA00:59:33 : Pourquoi il faut apprendre à coder en 202501:07:21 : La fin de l'ère des SaaS (software as a service)01:12:40 : Comment ne pas être remplacé par une IA (disparition des "jobs à la con”)01:22:20 : Commencer dès aujourd'hui à utiliser les automatisations dans sa vie pro01:28:48 : Comment devenir un ninja de Notion et Zapier01:37:15 : Se lancer sur YouTube et rester éthique face aux “influvoleurs”01:54:51 : La première vidéo à faire quand on se lance sur YouTube02:06:38 : L'Inde : pays de la débrouillardise et de la technologie02:15:24 : N'attendez pas pour vous lancerLes anciens épisodes de GDIY mentionnés :Marc Fiorentino - MonFinancier.com - la dure transition de Trader à EntrepreneurJulie Chapon - Yuka - Se lancer aux US grâce à TikTokNous avons parlé de :Shubham Sharma sur YouTubeLe site de Shubham et ses formationsCombien ça gagne (avec Clémence Lepic)L'étincelleNotionNoCode Summit 2024Matt WolfeNotebookLMLe document de Mr BeastMakePerplexityGammaVidéo sur l'Inbox zéroIFTTT : if this, then that, c'est-à-dire « Si ceci, alors cela »ZapierEric Schmidtz chez Diary of a CEOÇa vaut le coup ? calculateur en ligneMistral AIGaryVeeLa MartingaleLes recommandations de lecture : The Art of Exceptional LivingVous pouvez contacter Shubham sur Linkedin, Instagram.La musique du générique vous plaît ? C'est à Morgan Prudhomme que je la dois ! Contactez-le sur : https://studio-module.com. Vous souhaitez sponsoriser Génération Do It Yourself ou nous proposer un partenariat ? Contactez mon label Orso Media via ce formulaire.
Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain dive into the recent FDA approval of Zanidatamab, a bispecific HER2 antibody, for HER2 amplified, unresectable, locally advanced, or metastatic biliary tract cancer. Join us as we discuss the HERIZON-BTC-01 study with Dr. Shubham Pant, a GI medical oncologist at MD Anderson Cancer Center and one of the study's authors. We explore the significance of HER2 testing in biliary tract cancers, the study's design, key findings, and the implications for treatment strategies in the community oncology setting. Key topics include: • Overview of biliary tract cancer and its treatment landscape • Study design and patient characteristics from the HERIZON-BTC-01 trial • Key findings, including overall response rates and duration of response • The importance of HER2 testing and its implications for treatment sequencing • Side effect profiles and management strategies for Zanidatamab • Future directions and ongoing clinical trials Don't miss this insightful discussion that highlights the exciting advancements in HER2-targeted therapies for biliary tract cancer. Make sure to subscribe for more updates on recent FDA approvals, treatment algorithms, and conference highlights. We look forward to seeing you at GI ASCO 2025 in person! Website: http://www.oncbrothers.com/ X/Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com
In this episode of Path Monk Presents, we talk to Shubham Khoker, Head of Growth at Topmate, about the platform's role in enabling creators to monetize their expertise and knowledge. Topmate offers solutions for professionals to manage virtual consultations, webinars, and digital resources, providing opportunities for people to earn income from their skills. Shubham shares insights into how Topmate supports creative individuals and businesses, empowering them to transition from traditional 9-to-5 jobs to successful entrepreneurial ventures. Tune in for a deep dive into how Topmate is changing the game for creators and entrepreneurs.
Bienvenue dans cet épisode spécial du NoCode Summit 2024, où nous avons le plaisir de retrouver Shubham Sharma, une des figures incontournables du NoCode en France. Entrepreneur, YouTuber, et expert de l'automatisation NoCode, Shubham est connu pour démocratiser l'accès aux outils technologiques qui transforment notre façon de créer et d'innover. Dans cet épisode, il partage avec nous son expérience au NoCode Summit et nous éclaire sur l'évolution impressionnante du NoCode, passé d'un simple outil de niche à une solution de transformation majeure pour les entreprises. Ensemble, nous discutons des attentes des grands groupes, de la structuration du marché, de l'impact de l'IA générative, et des pratiques qui permettent de maximiser la puissance du NoCode tout en gardant en tête l'importance de l'architecture et de la stratégie produit. Un épisode riche en perspectives, conseils et vision pour les entrepreneurs et passionnés de tech qui cherchent à booster leurs projets grâce au NoCode. Bonne écoute ! Ressources citées : Linkedin Shubham : linkedin.com/in/sharmashubham1 Chaîne Youtube : youtube.com/@Shubham_Sharma Site web : www.shubham-sharma.fr Outils mentionné : Make Notion Vidéo sur les 10 outils qui ont transformé la manière de travailler de Shubham Retrouvez tous les livres recommandés par les invités du podcast dans la bibliothèque Open Startup : https://bit.ly/livresOSP Si vous avez aimé cet épisode alors je vous recommande les suivants : Retour sur le Nocode Summit 2023 Envie de proposer un invité ? Direction ce formulaire → https://bit.ly/3gSqwKx Avant de partir Cela me ferait plaisir aussi d'avoir de vos nouvelles, vous pouvez me contacter sur Linkedin ou Instagram. Si cet épisode vous a été utile, pensez à vous abonner sur votre app' de podcast préférée comme Apple Podcasts ou Spotify. D'ailleurs si le podcast vous plaît et que vous souhaitez me le dire, le meilleur moyen c'est de laisser un avis 5 étoiles sur Apple Podcasts. Allez-y ça ne coûte rien et m'aide beaucoup!
Today's guest is Shubham Shrivastava, Head of Machine Learning at Kodiak. Founded in 2018, Kodiak is the trusted world leader in autonomous ground transportation committed to a safer and more efficient future for all. Through the endless demands of a world in constant motion, Kodiak helps you get the job done. With purpose-built solutions to power autonomous movement in any environment, Kodiak make sure their partners save time, run clean and keep safe. Shubham is a passionate and innovative leader in the field of machine learning and computer vision, with a focus on 3D perception and autonomous vehicles. As the Head of ML at Kodiak, he is building the world's safest driver, using his extensive experience and skills in developing and deploying vision-centric 3D perception solutions. Previously, Shubham has led a team of talented researchers at Ford Autonomy, where he created an end-to-end 3D Perception stack for Ford L2+ vehicles, and a scalable cloud-based ML framework for all ML tasks within Ford. In this episode, Shubham talks about: His journey to date in leading autonomous trucking advancements, How Kodiak pioneers autonomous trucking and driverless vehicle operations, Developing resilient, modular AI for autonomous systems, Scaling autonomous fleets with sparse and rapid mapping, Kodiak's aim to scale a 24/7 driverless fleet, Seeking motivated talent to advance AI and transform the industry, Why Kodiak is a great place to work
Listen to the story of Ishpal, Serina from and Shubham from Kind Kones. Headquartered in Singapore, Kind Kones is more than an ice-cream company — it's a movement for kindness, inclusivity, and joy. It is Southeast Asia's leading plant-based dessert brand. Guided by the philosophy of "being kind," their message is clear - "Be kind to your body, the environment, and to others." Indulge in vegan, gluten-free, and guilt-free desserts (ice-cream, cakes, and cookies!) and say goodbye to all refined sugar and artificial additives.At publication of this episode, Kind Kones is actively raising funds. Angel investors Reshmi Rajendran and Anne Schot join the Investor Talk at the end of this podcast (33:20).Hosted by Maaike Doyer and Hester Spiegel, founders of Epic Angels.
From Wednesday's Bulls Beat, one of the starting members of the men's golf squad and one of the best student-athletes on campus.
There is more to Shubham Ranjane than merely following the rich cricketing tradition in his family. After making his Maharashtra debut in limited overs cricket, he moved from his hometown Pune to Mumbai in search of opportunities and recognition. Limited opportunities with Mumbai forced him to play for Goa as a professional for a season before shifting to the United States of America in 2022. What is it that he is looking for? Let's try and find out from Shubham, who joins in Kattyawarchya Gappa from Houston. शुभम रांजणेकडे केवळ त्याच्या कुटुंबातील समृद्ध क्रिकेट परंपरा पुढे चालवण्याहून बरंच काही आहे. मर्यादित षटकांच्या क्रिकेटमध्ये महाराष्ट्रासाठी पदार्पण केल्यानंतर तो त्याचे मूळ गाव पुण्याहून मुंबईला गेला. २०२२ मध्ये युनायटेड स्टेट्स ऑफ अमेरिका येथे स्थलांतरित होण्यापूर्वी मुंबईतील मर्यादित संधींमुळे त्याला गोव्यासाठी व्यावसायिक खेळाडू म्हणून खेळायला भाग पाडले. शुभमला नक्की ध्यास कुठल्या गोष्टीचा आहे, जाणून घेऊया कट्ट्यावरच्या गप्पांम
Inspired by the old and the new, this radio show takes you through the journey of our beloved electronic music genre, drum and bass. Right from The Amen sample all the way to the new age bass stalwarts, this series promises to take you on a journey through wobbling basslines and futuristic loops. Enjoy and keep raving. Follow Shubham (@shubsham) ◊ www.instagram.com/shubsham_/ ◊ twitter.com/mushkilwaqt ◊ https://www.facebook.com/expertpwnershubham/ ◊ @shubsham ————— Follow MSYH.FM » MSYH.FM » twitter.com/MSYHFM » instagram.com/MSYH.FM » facebook.com/MSYH.FM » mixcloud.com/MSYHFM ————— Follow Make Sure You Have Fun™ ∞ MakeSureYouHaveFun.com ∞ twitter.com/MakeSureYouHave ∞ instagram.com/MakeSureYouHaveFun ∞ facebook.com/MakeSureYouHaveFun
5 years ago, Shubham had just graduated college and had no network. He bootstrapped to $3M in ARR, then raised $200M & grew to $85M ARR.But he started trying to sell AI for marketing to enterprises with no network.So for 2 months, he'd go to the lobby of a bank and sit there for an hour. He'd wait for the CMO to walk by, just so he could say hi. He'd tell receptionists he was waiting for an interview. Finally, one day the CMO had enough and asked him who he was. Shubham got his 15-minute moment. That turned into a free pilot. That free pilot turned to $1.2M ARR. 2 years after he'd started the company, he bootstrapped to $3M ARR and was profitable— since then, the growth never stopped. Why you should listenHow to start a startup top-down from a market vs bottoms-up from customer problems.Why doing insane things in the early days can lead to insane results.How Founder-led sales and tight feedback loops are the key for product development and customer success.KeywordsAI startup, product market fit, challenges, marketing, scaling, fundraisingTimestamps(00:00:00) Intro(00:01:52) Origin Story of Pixis(00:07:05) Getting the First Customers(00:09:14) What is Pixis(00:11:26) Video Generation(00:14:54) Finding the Problem Going Top-Down(00:19:55) The Pitch(00:24:30) The First Pilot(00:27:08) Scaling the Team(00:31:57) Raising the First Round(00:33:59) The AI Market(00:35:54) Finding True PMF(00:37:13) One Piece of AdviceSend me a message to let me know what you think!
The Latest Data on Zanidatamab for Biliary Tract Cancer: Shubham Pant, MD by i3 Health
June is Pride Month! And in honor of this, we want to highlight the various kinds of Gender Affirming Surgery and medical care.So what is Gender Affirming Surgery? Gender Affirming Surgery (GAS), also known as gender confirmation surgery or sex reassignment surgery, encompasses a variety of surgical procedures that some transgender and non-binary individuals may choose to undergo to align their physical appearance with their gender identity. These procedures can be broadly categorized into chest surgeries, genital surgeries, facial surgeries, and other body contouring procedures. Here's a more detailed breakdown:The primary aim of gender affirming surgery is to alleviate gender dysphoria, a condition where there is a significant incongruence between one's gender identity and their physical sex characteristics. These surgeries can have profound psychological and social benefits, improving quality of life and mental health for many individuals.Let's find out more from Dr. Shubham Gupta, Chief of Reconstructive Urology at University Hospitals, Cleveland Medical Center.Dr. Shubham Gupta focuses his clinical practice on genitourinary reconstruction and cancer survivorship. His expertise includes the diagnosis and treatment of urethral stricture disease, Peyronie's disease, erectile dysfunction, and male urinary incontinence. He has a special interest and extensive experience in managing complex intra-abdominal strictures, fistulas, and radiation sequelae. Additionally, utilizing multi-disciplinary collaborative models, he provides advanced care to transgender patients, including gender-affirming surgery.Featured in this episode: Types of gender affirming surgery Sexuality and GAS The difference between transfeminine and transmasculine procedures The difference between sexual orientation and gender identity Not all transgender or non-binary individuals pursue surgery as part of their transitionSubmit your questions on anything and everything women's health-related and we will answer them in one of our episodes.Want more from Our Womanity?If you enjoyed this episode of Womanity, please subscribe, rate, and leave a review. Your feedback helps us continue to bring you engaging and empowering content.Follow us on social media: Instagram: @drrpope TikTok: @vulvadoctor Twitter: @drrpope LinkedIn
Préparez-vous à passer 1h dans la tête de Shubham Sharma, créateur et entrepreneur sur des sujets automatisation, organisation et IA. Si vous connaissez déjà Shubham, vous vous dites qu'il a percé grâce à Youtube et ses vidéos sur la productivité.Et si je vous disais que Shubham est un OVNI qui avait préparé son coup depuis des années…CHAPITRAGE :00:00 : Le début04:30 : sa prochaine intention business07:35 : comment prendre des risques16:30 : le déclic qui l'a transformé23:00 : sa stratégie Youtube28:40 : technicien VS créateur40:55 : masterclass pricing freelance49:20 : sa double face (intensité et kiff)58:44 : ses rôles modèles01:09:00 : ses peurs d'échouer01:13:00 : créer des systèmes VS actions--Un grand merci à Abby de soutenir mon travail. Je suis passé à 2 doigts d'investir chez eux il y a 1 an, alors très content de les compter en partenaire. Abby vous permet de gérer et piloter toute la partie admin + financière de votre entreprise.Test gratuit (sans CB) juste ici : https://abby.fr/Et si vous tombez amoureux de l'outil, vous avez 35% de réduction avec le code TRIBU35.Faites-moi vos retours en commentaire pour améliorer le format !
In this insightful article, delve into the fascinating journey and experiences of Shubham Singhal, Co-Founder & CEO of Dot Media, a prominent digital marketing company based in Mumbai, India. From the challenges of starting a venture during the lockdown to navigating the diverse landscape of influencer marketing, Shubham shares valuable insights and strategies for brands looking to make an impact in the digital realm. Explore the role of technology, data analytics, and storytelling in shaping effective marketing campaigns, and gain valuable foresight into the future trends that will shape the industry. Whether you're a seasoned marketer or a budding entrepreneur, there's plenty to learn from Shubham's expertise and vision for the future of digital marketing. 00:52- About Shubham Singhal Shubham is the co-founder and chief executive officer of Dot Media, a digital marketing company. He has worked with over 2000+ Artists, Creators & Actors across all genres. --- Support this podcast: https://podcasters.spotify.com/pod/show/tbcy/support
Chez Squared, on rassemble des entrepreneurs pour qui la notion de liberté est très importante. Notre mission d'ailleurs, au travers de nos masterminds, c'est de libérer l'entrepreneur (au travers de la structure : système, process, équipe) pour qu'il ou elle puisse libérer tout le potentiel de croissance de son entreprise.La liberté ?C'est aussi celle de pouvoir voyager et s'il y a bien un point commun (encore un) entre nos 2 invités, c'est qu'ils sont “rarement” chez eux. Toujours dans un coin ou l'autre de la planète. La liberté, les voyages, ce sont des valeurs fortes.Nos questions : Comment intègrent-ils ces voyages dans leur business ? Quels sont les points de frictions ? Comment y remédier ?Quelle est leur approche plus globalement sur le sujet liberté et business ?Pour le découvrir, écoutez notre nouvel épisode Structure
Aujourd'hui, on se penche sur les parcours de Shubham et Steven, qui ont tous deux commencé leur carrière professionnelle loin de l'univers de l'infopreneuriat.Issu, chacun, de 2 industries différentes : Shubham a fait ses armes dans le monde dynamique des start-ups et de la tech, avec des expériences notables chez des acteurs comme Qonto.De son côté, Steven provient de l'univers de l'image et de la production audiovisuelle, ayant collaboré avec de grands groupes tels que La Roche-Posay.Ce qui nous frappe, c'est qu'ils sont devenus d'excellents ambassadeurs de ces 2 mondes (en mode caméléon) :Ils sont reconnus par leurs pairs.Ils sont pertinents dans leurs expertises.Nous avons une question pour eux, mais que chacun abordera sûrement différemment :Pour Shubham :Quels aspects du monde des start-ups t'ont été précieux en infopreneuriat ? Qu'as-tu pu transposer comme meilleures pratiques de la tech à ton business d'infopreneur ? Et à l'inverse, de quoi le monde des start-ups pourrait s'inspirer dans l'infopreneuriat ?Pour Steven : Quels éléments du secteur corporate t'ont aidé dans ton parcours d'infopreneur ? Quelles pratiques des grands groupes as-tu intégrées à ton entreprise infopreneuriale ? Et à l'inverse, quels enseignements les grandes entreprises pourraient-elles tirer de l'infopreneuriat ?Pour le découvrir, écoutez notre nouvel épisode Structure
Aujourd'hui, nous plongeons au cœur de Youtube et d'Instagram.Pourquoi ces plateformes ? Simplement parce que nos invités sont des experts reconnus, chacun dans son domaine respectif.D'un côté, nous avons Shubham leader en France sur Youtube du NoCode ainsi que d'autres sujets comme la growth et la productivité. D'autre part, nous avons Steven, dont Instagram n'a plus aucun secret. Un réseau sur lequel il excelle et sur lequel il fait exploser aussi les comptes de ses clients.Autant dire qu'avec ces 2 virtuoses, chaque conseil sur ces plateformes vaut son pesant d'or.L'épisode du jour est conçu comme une immersion de 24 heures dans leur quotidien numérique. Nous explorerons avec eux :Leurs stratégies pour aborder efficacement ces réseaux.Leur manière de travailler, que ce soit en solo ou en collaboration.Les détails auxquels ils prêtent une attention constante pour rester au sommet.On veut connaître tous leurs secrets sur leur manière d'appréhender ces 2 réseaux sociaux incontournables pour tout infopreneur.Pour le découvrir, écoutez notre nouvel épisode Structure
L'intelligence artificielle. Les “buzzwords” de 2022/2023 (toujours présents en 2024) Depuis que Chat GPT a été révélé au grand public, il y a toute une hype autour de ce sujet. De notre côté, chez Squared, on commence petit à petit à intégrer de l'intelligence artificielle ici et là. Mais une chose est sûre, si il y a bien 2 entrepreneurs qu'on suit plus que les autres sur ce sujet. C'est bien nos 2 invités du jour ! Shubham Sharma et Steven Herteleer Tout simplement parce qu'ils sont (très très) calés sur le sujet de l'IA.Mais ce qui nous fascine le plus, c'est l'art et la manière avec lesquelles ils implémentent l'IA dans leurs entreprises. Alors, on a 2 questions pour débuter notre conversation du jour :Que font-ils aujourd'hui avec l'IA et qu'ils ne faisaient pas avant ? LES trucs dont ils ne peuvent plus se passer désormais ? Comment (comme pour les automatisations - précédent épisode), approchent-ils l'IA dans leur business ? Pour le découvrir, écoutez notre nouvel épisode Structure
Young, Wild & Freelance | Le podcast pour ta vie d'indépendant
Dans cet épisode palpitant de "Young, Wild & Freelance", Thomas plonge au cœur des préoccupations actuelles d'énormément de freelances et entrepreneurs : l'intelligence artificielle. Alors que la vague de l'IA (et notamment de ChatGPT) est arrivée de toute force en 2023, en quelques mois elle s'intègre de plus en plus dans notre vie professionnelle. Dans cette conversation, Shubham Sharma et Thomas Burbidge explorent l'impact de cette technologie sur notre avenir, nos métiers et la société. Doit-on craindre ou embrasser l'IA dans nos entreprises ? Et comment rester compétitif dans un environnement en constante évolution ? Shubham et Thomas abordent des sujets cruciaux tels que la régulation de l'IA, son potentiel pour accentuer les inégalités sociales et osent même une comparaison intriguante entre l'IA et la course à l'arme atomique. Êtes-vous prêt à tirer parti de l'intelligence artificielle sans sacrifier l'humain dans votre activité freelance ? Ce débat riche d'enseignements offre des insights précieux sur la manière de naviguer dans l'écosystème entrepreneurial actuel, marqué par les avancées technologiques. Rejoignez-nous pour une discussion profonde sur comment l'intelligence artificielle façonne notre vision du travail, le rôle crucial de l'éducation et les réflexions clés écologiques derrière ces technologies. Cet épisode vous aidera à comprendre les enjeux de l'IA pour les freelances et entrepreneurs tout en conservant une approche éthique et durable dans leur business.Abonne toi au podcast pour ne rien manquer des épisodes suivants
Pour ce tout 1er épisode de cette nouvelle série, on aimerait vous parler d'automatisations dans le business.Le sujet n'est pas nouveau. Mais comme c'est un sujet sur lequel nos 2 invités sont sensibles… … limite une “philosophie de vie” pour eux et leur business. On voulait absolument en savoir plus ! Alors, on a 2 questions comme point de départ pour l'épisode du jour :Si on branchait des électrodes sur votre cerveau pour choper votre façon de penser autour des automatisations, votre manière d'appréhender ce pan dans votre business, ça ressemblerait à quoi ? Et qu'est-ce que vous conseillez à tout chef d'entreprise à ce sujet ? Pour le découvrir, écoutez notre nouvel épisode Structure
Comment booster votre business avec l'automatisation et le no-code ? Je vous dis tout !
TestTalks | Automation Awesomeness | Helping YOU Succeed with Test Automation
In this episode of the TestGuild Automation Podcast, host Joe Colantonio speaks with Shubham Jain, the maintainer of Keploy, an API testing platform. Shubham shares insights into creating testing magic with zero code using Keploy, a tool that captures live traffic and generates test cases and data mocks for efficient API testing. Shubham shares features of Keploy's integration with the software development life cycle and its potential use cases. Shubham also delves into the open-source community for Keploy, providing tips for contributors and sharing information about upcoming events for those interested in learning more. Listen in to discover valuable advice for improving your mocking and automation testing efforts, emphasizing the importance of realistic mocks that capture real behavior.
Shubham Shrivastava, Head of Machine Learning at Kodiak Robotics, discusses how AI is solving the increasing challenges within the long haul trucking industry, specifically with safety and driver supply. He also provides practical examples of Kodiak's safety strategy and redundancies they've put in place. Key discussion topics: How soon we can expect to see autonomous trucks on the road The balance between AI innovation and regulation, and how Kodiak is navigating regulation at both the state and national levels across the US Practical examples of how multimodal networks are already transforming various industries including education, healthcare, and robotics Collaboration gaps between academia and industry (and missed opportunities for advancement) Guest bio: Shubham Shrivastava is a leading figure in machine learning and computer vision. At Kodiak, he's the mastermind behind all machine learning endeavors, steering the development of the safest autonomous driving technologies. His leadership and innovations at Ford Autonomy, particularly in 3D perception for vehicles, have set new industry standards. Shubham's numerous patents and publications echo his pivotal role in advancing autonomous vehicle technology, and underline his commitment to transforming the future of transportation. ---------------------------------------------------------------------------------------- About this Show: The Brave Technologist is here to shed light on the opportunities and challenges of emerging tech. To make it digestible, less scary, and more approachable for all! Join us as we embark on a mission to demystify artificial intelligence, challenge the status quo, and empower everyday people to embrace the digital revolution. Whether you're a tech enthusiast, a curious mind, or an industry professional, this podcast invites you to join the conversation and explore the future of AI together. The Brave Technologist Podcast is hosted by Luke Mulks, VP Business Operations at Brave Software—makers of the privacy-respecting Brave browser and Search engine, and now powering AI everywhere with the Brave Search API. Music by: Ari Dvorin Produced by: Sam Laliberte
The heart of today's topic is developing trust in your ideas, even when they are innovative and outside the box. You'll learn what a Raga is, how Ragas help with healing, and how Dharma helps you move forward with ease in your purpose. Join us to learn more from my interesting guest!Dr. Shubham Kulkarni is “The Raga-Singing Ayurvedic Doctor,” a practicing Ayurvedic doctor and music therapist based in Pune and Mumbai, India. He works in renowned palliative hospice care centers and at his own private practice. In addition to his medical studies, he holds master's degrees in palliative care and psychology and is a music therapist and vocalist of Indian classical music. He has successfully conducted clinical research in the field of Ayurveda and on music therapy's effects on insomnia, stress, depression, dementia, cancer, and pregnancy care. Show Highlights:How music and Ayurveda became part of Dr. Shubham's life and workWhy he is interested in the applied knowledge of music and Ayurveda in concepts like mental health, palliative care, and death/dyingWhat the learning process was for Dr. Shubham to learn music and the practical application of musicHow parents, teachers, gurus, and books help us discover our Dharma as we learn discipline and trustWhat a Raga is, how it is viewed as medicine, and how it affects our emotions and feelingsHow Dr. Shubham uses sound therapy, music therapy, and Raga therapy therapeutically in the treatment of specific diseasesHow music therapy can be used effectively as a cure and for careWhat Dr. Shubham says to people who are unsure of their DharmaWhat his birth chart shows about his creativity and his desire to help people healDr. Shubham's advice to others who do innovative workHear Dr. Shubham's answers to rapid-fire questions about helpful advice, morning routine, and recommended books.Resources:Connect with Dr. Shubham Kulkarni: Facebook and InstagramBooks recommended by Dr. Shubham: Bhagavad Gita and On Death and Dying by Elizabeth Kubler-RossConnect with PaulaThe Cosmic Business Lab is now open! This is a year-long program with me going deep into the business strategies I've used to build my six-figure business. You'll get access to resources, courses, and three calls a month, plus bonus calls with guest experts. Are you ready to uplevel? Join here.Upgrade to the Cosmic Business Mastermind, which gives you personalized support with me and is limited to 20 people. Details are here, and you can book a call with me where we'll look at your business and your birth chart to see if the program is a fit. We start March 4th - and there are only 20 spaces total available (some are already booked!)Get the 2024 Astrology Guidebook and receive all my hand-picked lay-low and auspicious days for the year,...
I first met Shubham at a local event discussing mental health for entrepreneurs. Shubham reached out to me after the event to ask me some questions about starting and growing a podcast, but the conversation then turned into me learning a lot more about Shubham's career journey. In just the short span of 75 minutes, I learned about his story, his values, and how he chose the unconventional over what was perceived to be stable, traditional, and expected. At that moment, I realized that I MUST invite Shubham onto The Thought Leader Club Podcast and have him share his story and other candid stories on failure, self-doubt, and paving your own path. I am delighted to share that episode 150 of The Thought Leader Club Podcast (featuring Shubham) is now available on iTunes, Spotify, and YouTube. In this conversation, you'll hear about: Shubham's unexpected journey from a traditional path to becoming a co-founder Candid stories of failure, uncertainty, and self-doubt How family, cultural, etc backgrounds played a role in Shubham's career decisions and views on success Making time for non-work interests and hobbies; Being a life-long learner Advice to those who are questioning their current career situation and are deciding whether to make some changes Enjoy :) P.S. And if you loved the episode, you can 1️) Leave a 5-star rating and an awesome review, and 2️) Share the episode on your social media About Shubham: Shubham is the CTO/Co-founder at Airboxr - A data automation platform for DTC brands. He loves to build software systems and applications following the lean methodology. Outside of work, he's micro-ambitious about many things - music, travelling, writing, chess, psychology, philosophy. Connect with Shubham: LinkedIn: https://www.linkedin.com/in/shubh-kaushal/ Website: https://www.airboxr.com/
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PZU865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 27, 2024.Elevating Outcomes for HER2-Expressing GI Cancers: The Evolving Role of Molecularly Targeted Agents in BTC and GEA Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJosep Tabernero, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Boehringer Ingelheim International GmbH; Cardiff Oncology, Inc.; CARsgen Therapeutics; Chugai Pharmaceutical Co., Ltd.; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche Ltd; Genentech Inc; hC Bioscience, Inc.; Ikena Oncology; Inspirna, Inc.; Lilly; Menarini; Merck Serono; Merck Sharp & Dohme; Merus; Mirati Therapeutics Inc.; NeoPhore; Novartis AG; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology A/S; Scorpion Therapeutics; Seagen; Servier; SOTIO Biotech AG; Taiho; Takeda Oncology, ; and TOLREMO Therapeutics AG.Stock Shareholder in Oniria Therapeutics, Alentis Therapeutics, Pangaea Oncology and 1TRIALSP.Co-Chair/PlannerShubham Pant, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AskGene Pharma Inc.; Boehringer Ingelheim International GmbH; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Zymeworks Inc.Grant/Research Support from 4D Pharma; Amal Therapeutics; Arcus Biosciences; Astellas Pharma Inc.; BioNTech; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Elicio Therapeutics; Immuneering Corporation; ImmunoMET; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Lilly; Mirati Therapeutics, Inc.; NGM Biopharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer; Purple Biotech; Rgenix; Xencor; and Zymeworks Inc. All goes to Institution.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PZU865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 27, 2024.Elevating Outcomes for HER2-Expressing GI Cancers: The Evolving Role of Molecularly Targeted Agents in BTC and GEA Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJosep Tabernero, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Boehringer Ingelheim International GmbH; Cardiff Oncology, Inc.; CARsgen Therapeutics; Chugai Pharmaceutical Co., Ltd.; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche Ltd; Genentech Inc; hC Bioscience, Inc.; Ikena Oncology; Inspirna, Inc.; Lilly; Menarini; Merck Serono; Merck Sharp & Dohme; Merus; Mirati Therapeutics Inc.; NeoPhore; Novartis AG; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology A/S; Scorpion Therapeutics; Seagen; Servier; SOTIO Biotech AG; Taiho; Takeda Oncology, ; and TOLREMO Therapeutics AG.Stock Shareholder in Oniria Therapeutics, Alentis Therapeutics, Pangaea Oncology and 1TRIALSP.Co-Chair/PlannerShubham Pant, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AskGene Pharma Inc.; Boehringer Ingelheim International GmbH; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Zymeworks Inc.Grant/Research Support from 4D Pharma; Amal Therapeutics; Arcus Biosciences; Astellas Pharma Inc.; BioNTech; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Elicio Therapeutics; Immuneering Corporation; ImmunoMET; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Lilly; Mirati Therapeutics, Inc.; NGM Biopharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer; Purple Biotech; Rgenix; Xencor; and Zymeworks Inc. All goes to Institution.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PZU865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 27, 2024.Elevating Outcomes for HER2-Expressing GI Cancers: The Evolving Role of Molecularly Targeted Agents in BTC and GEA Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJosep Tabernero, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Boehringer Ingelheim International GmbH; Cardiff Oncology, Inc.; CARsgen Therapeutics; Chugai Pharmaceutical Co., Ltd.; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche Ltd; Genentech Inc; hC Bioscience, Inc.; Ikena Oncology; Inspirna, Inc.; Lilly; Menarini; Merck Serono; Merck Sharp & Dohme; Merus; Mirati Therapeutics Inc.; NeoPhore; Novartis AG; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology A/S; Scorpion Therapeutics; Seagen; Servier; SOTIO Biotech AG; Taiho; Takeda Oncology, ; and TOLREMO Therapeutics AG.Stock Shareholder in Oniria Therapeutics, Alentis Therapeutics, Pangaea Oncology and 1TRIALSP.Co-Chair/PlannerShubham Pant, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AskGene Pharma Inc.; Boehringer Ingelheim International GmbH; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Zymeworks Inc.Grant/Research Support from 4D Pharma; Amal Therapeutics; Arcus Biosciences; Astellas Pharma Inc.; BioNTech; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Elicio Therapeutics; Immuneering Corporation; ImmunoMET; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Lilly; Mirati Therapeutics, Inc.; NGM Biopharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer; Purple Biotech; Rgenix; Xencor; and Zymeworks Inc. All goes to Institution.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.
For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PZU865. CME/NCPD/CPE/AAPA/IPCE credit will be available until November 27, 2024.Elevating Outcomes for HER2-Expressing GI Cancers: The Evolving Role of Molecularly Targeted Agents in BTC and GEA Care In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Cholangiocarcinoma Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent medical education grant from Jazz Pharmaceuticals.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerJosep Tabernero, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Boehringer Ingelheim International GmbH; Cardiff Oncology, Inc.; CARsgen Therapeutics; Chugai Pharmaceutical Co., Ltd.; Daiichi Sankyo, Inc.; F. Hoffmann-La Roche Ltd; Genentech Inc; hC Bioscience, Inc.; Ikena Oncology; Inspirna, Inc.; Lilly; Menarini; Merck Serono; Merck Sharp & Dohme; Merus; Mirati Therapeutics Inc.; NeoPhore; Novartis AG; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology A/S; Scorpion Therapeutics; Seagen; Servier; SOTIO Biotech AG; Taiho; Takeda Oncology, ; and TOLREMO Therapeutics AG.Stock Shareholder in Oniria Therapeutics, Alentis Therapeutics, Pangaea Oncology and 1TRIALSP.Co-Chair/PlannerShubham Pant, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AskGene Pharma Inc.; Boehringer Ingelheim International GmbH; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Zymeworks Inc.Grant/Research Support from 4D Pharma; Amal Therapeutics; Arcus Biosciences; Astellas Pharma Inc.; BioNTech; Boehringer Ingelheim International GmbH; Bristol Myers Squibb; Elicio Therapeutics; Immuneering Corporation; ImmunoMET; Ipsen Pharma; Janssen Pharmaceuticals, Inc.; Lilly; Mirati Therapeutics, Inc.; NGM Biopharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer; Purple Biotech; Rgenix; Xencor; and Zymeworks Inc. All goes to Institution.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.
Our next guest is Shubham Datta, the Vice President of Corporate Development at CLIO. As a key figure in overseeing the development and execution of CLIO's strategic growth strategy through acquisitions and investments, Shubham brings forth a wealth of knowledge and a unique perspective on the intricacies of how CLIO collaborates with third-party integrations and more. Shubham is a seasoned Mergers and Acquisitions (M&A) professional driving innovation in the legal tech space. With an extensive background in both buy-side and sell-side M&A, he spearheads efforts to align CLIO's product roadmap with cutting-edge companies. Join Shubham and me as we discuss the following three questions and more! 1. What are the top three criteria to prioritize when evaluating third-party application integrations? 2. How to determine what might be considered unnecessary or incompatible with CLIO platform, possibly without the requirement for specific categories? 3. In what aspects should legal professionals focus on when assessing new third-party applications for use in CLIO or when comparing them to competitors? In our conversation, we cover the following: [01:44] The Three Pillars of Effective Third-Party Integration in CLIO's Legal Tech Ecosystem [05:13] Core Legal Workflows in CLIO's Ecosystem [06:55] App Adoption and Integration Challenges in Legal Tech [09:00] Empowering Legal Innovation: Nuanced Challenges in App Integration [10:42] A Guide for Lawyers in Choosing Third-Party Apps for CLIO and Beyond [11:25] Future-Forward Legal Tech [13:12] AI Innovations to Elevate Legal Practice [14:58] CLIO: Redefining Legal Practice Management Resources: Connect with Shubham: LinkedIn: linkedin.com/in/shubhamdatta/ Software mentioned in the conversation: CLIO: CLIO.com/
The Desi VC: Indian Venture Capital | Angel Investors | Startups | VC
Shubham Goel is the Co-foudner and Co-CEO of Affinity, a relationship intelligence platform for dealmakers. The company has raised over $120M in funding from Menlo Ventures, MassMutual Ventures, Pear VC and Advance Venture Partners. Prior to Affinity, Shubham completed his BS in Computer Science at Stanford University. . . . Episode notes: What made Shubham pick entrepreneurship (2:00) Propensity of risk increasing as the company grows (6:08) The journey until the ah-ha moment (10:06) The aha-moment (17:00) Unlocking the operator and leader persona as a founder (25:15) Getting the most out of your teams as a leader (31:10) Things that have surprised Shubham in the company building journey (37:15) What would Shubham do differently if he were to build Affinity from scratch today? (43:54) . . . Social links: Follow Shubham on Twitter Follow The Desi VC Podcast on Twitter Follow Akash Bhat on Twitter
Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)
818: Lakshman Nathan, CIO of Paramount, and Shubham Mehrish, Global VP of Mars, join Metis Strategy Co-Head of Research, Media, and Executive Networks Steven Norton on a panel at our most recent Metis Strategy Digital Symposium to discuss the topic of talent strategy in the age of artificial intelligence. Both executives give their perspectives on the general evolution of the talent landscape, the impacts that AI is having on the skills they are hiring for, and use cases for generative AI on internal learning. Each shares his view on the financial component of talent and AI strategies, in-house solutions on cost control, and other opportunities and challenges that AI poses on a company's talent management strategy.
Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)
818: Lakshman Nathan, CIO of Paramount, and Shubham Mehrish, Global VP of Mars, join Metis Strategy Co-Head of Research, Media, and Executive Networks Steven Norton on a panel at our most recent Metis Strategy Digital Symposium to discuss the topic of talent strategy in the age of artificial intelligence. Both executives give their perspectives on the general evolution of the talent landscape, the impacts that AI is having on the skills they are hiring for, and use cases for generative AI on internal learning. Each shares his view on the financial component of talent and AI strategies, in-house solutions on cost control, and other opportunities and challenges that AI poses on a company's talent management strategy.
This episode marks our 3rd special Clio Con episode, and we're thrilled to have a distinguished guest from Clio, a trailblazer in the legal tech industry.Clio Con is an annual event hosted by Clio, a leading legal technology company dedicated to making legal services more accessible and efficient. With a mission to transform the legal experience for all, Clio provides innovative solutions for lawyers and legal professionals.Our guest Shubham Datta, the Vice President of Corporate Development at Clio, plays a pivotal role in driving Clio's growth and innovation. His remarkable impact on the legal tech industry is palpable as he shares insights into Clio's strategic growth strategy. Don't miss our discussion on the future of the legal tech landscape and what lies ahead for Clio in terms of corporate development. Additionally, discover the $3 trillion opportunity in the legal labor market as highlighted in Clio's Legal Trends Report.Finally, mark your calendar for Clio Con 2024 in Austin, Texas. Be part of the excitement, innovation, and connections. Together, we're transforming the legal experience for all.For more information on Clio, check out their website at www.clio.com and explore Clio's Legal Trends Report for valuable insights into the legal industry's evolution here.Learn more about Shubham Datta via LinkedIn.Support the show
Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)
798: Shubham Mehrish, Global Vice President at Mars, discusses how he is developing a digital, technology, and associate strategy based on a modular architecture approach that is focused on microservices, API-driven, Cloud-native, and Headless. Discover how Shubham builds an ecosystem of talent internally and externally, applies data and AI to differentiate the business, and embraces design thinking and collaboration across the firm all with the aim of developing a digital customer experience to enhance the traditional tactile experience. Shubham also talks more broadly about how he pushes his team to learn from experiences regardless of their success and approach challenges with what notes as a comp[any-wide collective confidence. This translates more specifically to how his team is experimenting with generative AI and the other technology trends that are on his radar. Finally, Shubham describes the mental models he has applied in his role and recommends a few critical readings that he has found helpful in his career. Emotional Intelligence by Daniel Goleman What Got You Here Won't Get You There by Marshall Goldsmith Build by Tony Fadell
Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)
798: Shubham Mehrish, Global Vice President at Mars, discusses how he is developing a digital, technology, and associate strategy based on a modular architecture approach that is focused on microservices, API-driven, Cloud-native, and Headless. Discover how Shubham builds an ecosystem of talent internally and externally, applies data and AI to differentiate the business, and embraces design thinking and collaboration across the firm all with the aim of developing a digital customer experience to enhance the traditional tactile experience. Shubham also talks more broadly about how he pushes his team to learn from experiences regardless of their success and approach challenges with what notes as a comp[any-wide collective confidence. This translates more specifically to how his team is experimenting with generative AI and the other technology trends that are on his radar. Finally, Shubham describes the mental models he has applied in his role and recommends a few critical readings that he has found helpful in his career. Emotional Intelligence by Daniel Goleman What Got You Here Won't Get You There by Marshall Goldsmith Build by Tony Fadell
On Just A Filmy Game Show, Antariksh is joined by the duo from Funyaasi - Shubham Singh and Dhruv Bisht, to see who among them is the Biggest Bollywood Deewana. Shubham and Dhruv sang songs of Emraan Hashmi, named movies of Abhishek Bachchan, and tried to guess how much Gadar 1 and OMG 1 made in their box office run back when they released. Tune in! Follow our host Antariksh on Instagram: https://www.instagram.com/antariksht/ Follow Funyaasi on Instagram: https://www.instagram.com/funyaasi/ Follow Shubham on Instagram: https://www.instagram.com/shubshubolo/ Follow Dhruv on Instagram: https://www.instagram.com/dhruvbisht29/ Subscribe to IVM POP on YouTube: https://www.youtube.com/@IVMPop Follow IVM POP on Instagram! : https://www.instagram.com/ivmpop/ This Show is Available across audio Platforms: Spotify | Gaana | Apple Podcasts | Google Podcasts The views, opinions, and statements expressed in the episodes of the shows hosted on the IVM Podcasts network are solely those of the individual participants, hosts, and guests, and do not necessarily reflect the official policy or position of IVM Podcasts or its management. IVM Podcasts does not endorse or assume responsibility for any content, claims, or representations made by the participants during the shows. This includes, but is not limited to, the accuracy, completeness, or reliability of any information provided. Any reliance you place on such information is strictly at your own risk. IVM Podcasts is not liable for any direct, indirect, consequential, or incidental damages arising out of or in connection with the use or dissemination of the content featured in the shows. Listener discretion is advised.See omnystudio.com/listener for privacy information.
FULL SHOW NOTEShttps://podcast.nz365guy.com/476Ready to unravel the world of Dynamics 365 Business Central and the Power Platform? Join us as we delve into an insightful conversation with our distinguished guest, Gulshan Shubham, a triumph in the field and a proud recipient of the MVP award in 2022. Currently a Senior Advisory Consultant at IBM, he originates from India, a fact that flavours his intriguing journey in Business Central, his penchant for South Indian cuisine, and his hobbies that include series binging, cricket, and badminton. Listen to him articulate his evolution from a coder to a functional consultant and his unwavering commitment to disseminating his profound knowledge to the Dynamics community. Gulshan, with his astute understanding of Dynamics 365 Business Central, has plenty to share about its edge over Oracle NetSuite, particularly for SMB software. He also throws light upon the integration of the Power Platform with Dynamics 365 Business Central - a field where he and his team at IBM are making significant progress. Furthermore, his journey to earning the MVP title is nothing short of an inspirational tale for anyone passionate about Dynamics 365 Business Central. With a firm belief in sharing his knowledge, Gulshan's recognition has only fueled him to become more responsible and knowledgeable as a consultant. Don't let this chance slip by to learn from one of the stalwarts of the industry!OTHER RESOURCES: Microsoft MVP YouTube Series - How to Become a Microsoft MVP 90-Day Mentoring Challenge - https://ako.nz365guy.com/ AgileXRM AgileXRm - The integrated BPM for Microsoft Power PlatformSupport the showIf you want to get in touch with me, you can message me here on Linkedin.Thanks for listening
A big thanks to the following sponsors for making the podcast a reality! Mitimco This episode is brought to you by MIT Investment Management Company, also known as MITIMCo, the investment office of MIT. Each year, MITIMCo invests in a handful of new emerging managers who it believes can earn exceptional long-term returns in support of MIT's mission. To help the emerging manager community more broadly, they created emergingmanagers.org, a website for emerging manager stockpickers. For those looking to start a stock-picking fund or just looking to learn about how others have done it, I highly recommend the site. You'll find essays and interviews by successful emerging managers, service providers used by MIT's own managers, essays MITIMCo has written for emerging managers and more! Tegus Tegus has the world's largest collection of instantly available interviews on all the public and private companies you care about. Tegus actually makes primary research fun and effortless, too. Instead of weeks and months, you can learn a new industry or company in hours, and all from those that know it best. I spend nearly all my time reading Tegus calls on existing holdings and new ideas. And I know you will too. So if you're interested, head on over to tegus.co/valuehive for a free trial to see for yourself. TIKR TIKR is THE BEST resource for all stock market data, I use TIKR every day in my process, and I know you will too. Make sure to check them out at TIKR.com/hive. Marhelm Marhelm is an information service for investors to find real value in an overvalued market. With a focus on shipping and commodities, Marhelm helps you stay on the pulse of global trade, track global sentiment, and identify compelling investment opportunities. Get 20% of your subscription by using the code VALUE at checkout. Check it out here. --- Support this podcast: https://podcasters.spotify.com/pod/show/valuehive/support
We received an update on Prospera Energy (
© 2020-2025 Ivy Podcast Discovery LLC
